A detailed history of Park Place Capital Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Park Place Capital Corp holds 1,000 shares of NVO stock, worth $111,950. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,000
Holding current value
$111,950
% of portfolio
0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$119.07 - $145.42 $119,070 - $145,420
1,000 New
1,000 $119,000
Q3 2023

Oct 17, 2023

BUY
$90.94 - $199.54 $28,827 - $63,254
317 Added 118.73%
584 $53,000
Q2 2023

Aug 04, 2023

SELL
$155.98 - $172.65 $45,702 - $50,586
-293 Reduced 52.32%
267 $43,000
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $57,428 - $75,784
560 New
560 $76,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Park Place Capital Corp Portfolio

Follow Park Place Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Place Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Park Place Capital Corp with notifications on news.